Skip to content

Octave Bioscience Appoints Zachary Fernandes as VP of Business Development

Octave Bioscience announces the appointment of Zachary Fernandes as Vice President of Business Development to enhance its strategic partnerships and drive revenue growth in the field of precision medicine for neurodegenerative diseases.

MENLO PARK, Calif.–(BUSINESS WIRE)–Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson’s and other neurodegenerative diseases, today announced the appointment of Zachary Fernandes as Vice President, Business Development. He will lead Octave’s partnership strategy focused on driving durable revenue growth through transformative, strategic collaborations across the life sciences ecosystem. Mr. Fernandes h